Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1944 USD | +2.29% |
|
-3.04% | -15.03% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 322M 281M 260M 244M 457M 30.42B 460M 3.09B 1.2B 14.97B 1.21B 1.18B 51.99B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 418M 365M 338M 316M 593M 39.49B 597M 4.01B 1.55B 19.44B 1.57B 1.54B 67.49B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.5x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.29% | ||
| 1 week | -3.04% | ||
| Current month | -14.17% | ||
| 1 month | -23.37% | ||
| 3 months | -11.27% | ||
| 6 months | -23.13% | ||
| Current year | -15.03% |
| 1 week | 0.19 |  | 0.2 |
| 1 month | 0.18 | | 0.25 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.29% | -3.04% | -27.89% | -69.62% | 322M | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| Average | +1.50% | +2.40% | +30.22% | +89.36% | 21.46B | |
| Weighted average by Cap. | +1.63% | +1.48% | +40.82% | +99.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.95M 31.44M 29.43M 55.2M 3.67B 55.53M 373M 145M 1.81B 146M 143M 6.28B |
| Net income | - | - |
| Net Debt | 96.08M 83.77M 77.59M 72.63M 136M 9.07B 137M 920M 357M 4.46B 361M 353M 15.49B | 125M 109M 101M 94.44M 177M 11.79B 178M 1.2B 464M 5.8B 469M 459M 20.15B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/26 | 0.1944 $ | +2.29% | 1,363,871 |
| 17/06/26 | 0.1900 $ | +0.43% | 2,768,029 |
| 16/06/26 | 0.1892 $ | -0.40% | 2,033,892 |
| 15/06/26 | 0.1900 $ | -5.23% | 1,412,437 |
| 12/06/26 | 0.2005 $ | +7.17% | 2,918,579 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1944USD
Average target price
1.000USD
Spread / Average Target
+414.40%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
